One recent autoantigen identified in patients with IIM is a muscle-specific antigen, Four-and-a-half-LIM-domain 1 (FHL1), which is highly expressed in skeletal and heart muscle [12, 13]. This evidence concerns the gene FHL1 and acquired idiopathic inflammatory myopathy.